Showing results (201-210 of 976) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|November 18, 2023
Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy dataNancy U Lin, Priya Kumthekar, Solmaz Sahebjam, et al.
NPJ Breast Cancer|October 11, 2023
Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)Naoki Niikura, Takashi Yamanaka, Hironori Nomura, et al.
NPJ Breast Cancer|September 20, 2024
Survival outcomes after omission of surgery for ductal carcinoma in situElizabeth C Poli, Wenli Dong, Simona F Shaitelman, et al.
NPJ Breast Cancer|June 2, 2023
Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancerAna C Garrido-Castro, Meredith M Regan, Samuel M Niman, et al.
NPJ Breast Cancer|May 31, 2023
Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancerMark Pegram, Christian Jackisch, Stephen R D Johnston
NPJ Breast Cancer|March 2, 2026
Neoadjuvant pembrolizumab plus chemotherapy in older patients with early-stage triple-negative breast cancer: real-world insights from neo-real/GBECAM-0123Mariana Carvalho Gouveia, Romualdo Barroso-Sousa, Laura Lapuchesky, et al.
NPJ Breast Cancer|November 29, 2024
Circulating tumor cells in breast cancer: clinical validity and utilityThibault Thomas-Bonafos, Jean Yves Pierga, François-Clément Bidard, et al.
NPJ Breast Cancer|February 10, 2018
Breast cancer risk factors and mammographic density among high-risk women in urban ChinaHyuna Sung, Jiansong Ren, Jing Li, et al.
NPJ Breast Cancer|May 12, 2026
Molecular profile of residual triple-negative breast cancer: opportunities for post-neoadjuvant therapeutic interventionsNadine S van den Ende, Marcel Smid, John W M Martens, et al.
NPJ Breast Cancer|May 23, 2026
WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and designAllison Fiscalini, Kelly Blum, Kirkpatrick Fergus, et al.
Pageof 98